Latest Articles
First Early Endometrial Cancer Detection Test Launched by Gnosis - Inside Precision Medicine
First Early Endometrial Cancer Detection Test Launched by Gnosis Inside Precision Medicine
Published: July 30, 2025, 6:06 p.m.
Gnosis Launches EdenDx, the First Non-Invasive Liquid-Based Cytology U.S. Test for Early Endometrial Cancer Detection - PR Newswire
Gnosis Launches EdenDx, the First Non-Invasive Liquid-Based Cytology U.S. Test for Early Endometrial Cancer Detection PR Newswire
Published: July 30, 2025, 3:04 p.m.
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights - Cureus
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights Cureus
Published: July 30, 2025, 7:21 a.m.
CIAPIN1 promotes survival, proliferation, migration and glycolysis of endometrial cancer cells through PI3K/Akt pathway - Nature
CIAPIN1 promotes survival, proliferation, migration and glycolysis of endometrial cancer cells through PI3K/Akt pathway Nature
Published: July 30, 2025, 1:56 a.m.
Bar Levy: New ESGO-ESTRO-ESP Guidelines for Endometrial Cancer - Oncodaily
Bar Levy: New ESGO-ESTRO-ESP Guidelines for Endometrial Cancer Oncodaily
Published: July 29, 2025, 2:43 p.m.
Endometrial Cancer Market on Track for Major Expansion by 2034, - openPR.com
Endometrial Cancer Market on Track for Major Expansion by 2034, openPR.com
Published: July 28, 2025, 8:10 p.m.
Application of MRI-guided hysteroscopic one-step resection in preserving fertility of early endometrial cancer patients - Frontiers
Application of MRI-guided hysteroscopic one-step resection in preserving fertility of early endometrial cancer patients Frontiers
Published: July 28, 2025, 8:14 a.m.
GSK’s Phase 2 Trial on Dostarlimab for Endometrial Cancer: A Market Game Changer? - TipRanks
GSK’s Phase 2 Trial on Dostarlimab for Endometrial Cancer: A Market Game Changer? TipRanks
Published: July 25, 2025, 4:19 p.m.
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer - Journal of Translational Medicine
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer Journal of Translational Medicine
Published: July 24, 2025, 9:25 p.m.
Research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women - Medical Xpress
Research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women Medical Xpress
Published: July 24, 2025, 2:29 p.m.
Link copied to clipboard!